Latest Private Placement News

Racura Oncology has hit key clinical milestones in its RC220 development, including first patient dosing in a lung cancer trial and dose escalation in a cardioprotection study, supported by a strong $34.3 million cash position.

Dotz Nano has appointed Nati Harpaz as CEO, introduced Dotz Energy to extend its decarbonisation efforts, and secured $3.3 million in fresh funding to accelerate commercialisation and production scale-up.

LinQ Minerals has delivered significant drilling results at its Gilmore Project, confirming a large shallow copper-gold porphyry system at Monza and extending high-grade gold-copper mineralisation at Dam. With a strong cash position and multiple assay results pending, the company is well placed for further exploration.

Janus Electric has locked in A$7.7 million through a private placement to bolster its growth in the North American electric heavy vehicle market, following a surge in orders.

HitIQ Limited attributes recent share price and volume spikes to a recent $1.4 million private placement and investor buying, denying any undisclosed material information.

Resouro Strategic Metals is set to raise up to C$2 million through a non-brokered private placement to fund pre-feasibility studies and metallurgical work at its flagship Tiros project in Brazil, building on a recent robust preliminary economic assessment.

Australian Unity has secured $200 million through a private placement of wholesale debt, using part of the proceeds to buy back $51.5 million of its Series D Bonds ahead of their December 2026 maturity.

Resouro Strategic Metals has unveiled a robust Preliminary Economic Assessment for its Tiros Titanium and Rare Earths Project, signalling a post-tax NPV of US$715 million and a 44.2% IRR over 20 years. Meanwhile, binding agreements for mining and processing at the Novo Mundo Gold Project promise to unlock additional value.

HITIQ Limited has secured $1.4 million through a private placement of 200 million shares at 0.7 cents each, accompanied by options exercisable until 2029. The capital will bolster its balance sheet and back expansion and commercialisation efforts.

Dotz Nano has secured A$3.3 million through a private placement, backing its next phase of production scale-up and customer engagement under incoming CEO Nati Harpaz.

Racura Oncology has raised $34.3 million through shareholder-backed initiatives, securing funding for its lead asset RC220’s clinical trials in AML, EGFRm lung cancer, and cardioprotection in solid tumour patients.

EPX Limited has locked in a $3 million senior secured revolving loan note facility with Partners for Growth, providing capital to seize new revenue opportunities and support working capital over the next three years.